However, similar to SGLT2 inhibitors, the potential mechanisms behind the renal effects of GLP1-RAs still need to be elucidated
Recent Posts What Houston Patients Should Know About GLP1 Medications for Diabetes and Weight Management GLP1 receptor agonists, commonly known by brand names like Ozempic, Wegovy, Trulicity and Mounjaro, have become widely discussed for their dual benefits: helping control type 2 diabetes and, in many cases, enabling significant weight loss
Contact your GP within 2448 hours for: Persistent pale or grey stools without jaundice Unexplained changes in stool colour lasting more than a few days Greasy, foul-smelling stools that float (steatorrhoea) suggesting fat malabsorption Stool changes accompanied by unexplained weight loss, fever, or night sweats Severe or persistent diarrhoea (more than seven days) or constipation unresponsive to usual measures It is particularly important to report stool changes if you have a history of gallbladder disease, pancreatitis, or inflammatory bowel conditions
structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial
Liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are all FDA-approved for weight loss
GLP-1 and cardioprotection: from bench to bedside
